News & Press Releases
A truly non-invasive glucose monitoring device that may improve diabetes management in patients with type 2 diabetes or prediabetes
September 7th, 2017
A truly non-invasive glucose monitoring device that may improve diabetes management in patients with type 2 diabetes or prediabetes Wilmington, Delaware, and Ashdod, Israel, September 7, 2017 — Integrity Applications, Inc. (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with type 2 diabetes, presents Data Demonstrating that the […]
Read More DownloadGlucoTrack® presents an innovation in type 2 diabetes management at the upcoming EASD in Lisbon, Portugal
September 6th, 2017
GlucoTrack® presents an innovation in type 2 diabetes management at the upcoming EASD in Lisbon, Portugal Wilmington, Delaware, and Ashdod, Israel, September 8, 2017 — Integrity Applications, Inc. (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with type 2 diabetes, announced today that it will be attending the 53rd […]
Read More DownloadIntegrity Applications Announces Close of $12 Million Private Placement
August 2nd, 2017
Integrity Applications Announces Close of $12 Million Private Placement Wilmington, Delaware, and Ashdod, Israel, August 2nd, 2017 — Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels in people with type 2 diabetes and pre-diabetes, announced today that it has successfully closed a private placement offering, raising approximately $12 […]
Read More DownloadIntegrity Applications Presents Data Demonstrating that the Accuracy of GlucoTrack® Is Independent of Medication Regime at American Diabetes Association’s 77th Scientific Sessions
June 12th, 2017
Integrity Applications Presents Data Demonstrating that the Accuracy of GlucoTrack® Is Independent of Medication Regime at American Diabetes Association’s 77th Scientific Sessions GlucoTrack Accuracy Maintained in People with Type 2 Diabetes Using a Variety of Medications for Comorbid Conditions 97.5% to 99.2% of GlucoTrack Glucose Measurements Maintain Clinically Acceptable A and B Zones […]
Read More DownloadIntegrity Applications, GlucoTrack® Innovator, Names David Podwalski as Chief Commercial Officer
June 8th, 2017
Integrity Applications, GlucoTrack® Innovator, Names David Podwalski as Chief Commercial Officer Wilmington, Delaware, and Ashdod, Israel, June 8, 2017 — Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels in people with type 2 diabetes and prediabetes, today announced the appointment of David Podwalski as Chief Commercial Officer. […]
Read More DownloadIntegrity Applications, GlucoTrack ® Innovator, Expands Board of Directors with the Appointment of Michael Hauck
May 25th, 2017
Wilmington, Delaware, and Ashdod, Israel, May 25, 2017 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels of people with type 2 diabetes and prediabetes, today announced the appointment of Michael Hauck to its Board of Directors. John Graham, CEO and Chairman of Integrity Applications, remarked, “We are […]
Read More DownloadIntegrity Applications to Present GlucoTrack® Data at American Diabetes Association’s 77th Scientific Sessions
May 23rd, 2017
Integrity Applications to Present GlucoTrack® Data at American Diabetes Association’s 77th Scientific Sessions Wilmington, Delaware, and Ashdod, Israel, May 23, 2017 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels of people with type 2 diabetes and prediabetes, today announced that the results of a study evaluating the […]
Read More DownloadIntegrity Applications Board Appoints Avner Gal as Chairman Emeritus and Scientific Advisor
April 18th, 2017
Integrity Applications Board Appoints Avner Gal as Chairman Emeritus and Scientific Advisor Ashdod, Israel, April [13], 2017 /PRNewswire/ — The Board of Directors of Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a noninvasive device for measuring glucose levels of people with Type 2 diabetes and pre-diabetics, announced that it has appointed Avner Gal as […]
Read More DownloadIntegrity Applications Board Appoints John Graham CEO and Chairman, Angela Strand Vice Chairman
March 27th, 2017
FOR IMMEDIATE RELEASE Integrity Applications Board Appoints John Graham CEO and Chairman, Angela Strand Vice Chairman Ashdod, Israel, March 27, 2017 /PRNewswire/ — The Board of Directors of Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a noninvasive device for measuring glucose levels of people with Type 2 diabetes and pre-diabetics, announced that it has […]
Read More DownloadGlucoTrack® Maker Presents Scientific Data Demonstrating Reliable Accuracy and Precision
February 16th, 2017
GlucoTrack® Maker Presents Scientific Data Demonstrating Reliable Accuracy and Precision Ashdod, Israel, February 16, 2017 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a noninvasive device for measuring glucose levels of people with Type 2 diabetes and pre-diabetics, announced that it is presenting this week at the 10th International Conference on Advanced Technologies […]
Read MoreIsrael 21C News– Test your glucose level without drawing blood
February 14th, 2017
We are proud to be illustrate in the Israel21C.org news on 2nd Feb, 2017. http://www.israel21c.org/test-your-glucose-level-without-drawing-blood Israeli maker of GlucoTrack believes its noninvasive meter will encourage people with Type 2 diabetes to check glucose levels more often. By Abigail Klein Leichman FEBRUARY 2, 2017, 4:20 PM GlucoTrack DF-F, Integrity Applications’ noninvasive glucose meter using an ear […]
Read MoreGlucoTrack® Maker Appoints New Chief Financial Officer
February 6th, 2017
GlucoTrack® Maker Appoints New Chief Financial Officer Ashdod, Israel, February 6, 2017 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels of people with Type 2 diabetes and pre-diabetics, announced today the appointment of Sami Sassoun as chief financial officer (CFO) effective February 1st, 2017. Mr. Sassoun […]
Read More DownloadGlucoTrack® maker to Present at the 9th Annual LD Micro Investor Conference on December 8th in Los Angeles
December 7th, 2016
GlucoTrack® maker to Present at the 9th Annual LD Micro Investor Conference on December 8th in Los Angeles LOS ANGELES, CA / ACCESSWIRE / December 5th, 2016 / Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels of people with Type 2 diabetes and pre-diabetics, announced that Angela Strand, […]
Read MoreGlucoTrack® Maker Names Two New Board Members
November 13th, 2016
GlucoTrack® Maker Names Two New Board Members Philip M. Darivoff, Former Goldman Sachs Partner, and Revan R. Schwartz Esq., Former General Counsel of Andrew Garrett, appointed effective November 9th, 2016 ASHDOD, Israel, Nov. 11, 2016 /PRNewswire/ Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a noninvasive device for measuring glucose levels of people with Type […]
Read More DownloadGlucoTrack® Maker to Present Updated Scientific Data Demonstrating Increased Accuracy
November 11th, 2016
GlucoTrack® Maker to Present Updated Scientific Data Demonstrating Increased Accuracy Presentation includes information from recently concluded German and Israeli Trials ASHDOD, Israel, Nov. 10, 2016 /PRNewswire/ Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a noninvasive device for measuring glucose levels of people with Type 2 diabetes and pre-diabetics, announced that it is presenting today […]
Read More DownloadGlucoTrack® Maker Announces Receipt of Final Regulatory Approval in South Korea
November 7th, 2016
GlucoTrack® Maker Announces Receipt of Final Regulatory Approval in South Korea Receives immediate first order from distributor ASHDOD, Israel, Nov. 7, 2016 /PRNewswire/ Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a noninvasive device for measuring glucose levels of people with Type 2 diabetes and pre-diabetics, announced today that it has received the final regulatory […]
Read More DownloadGlucoTrack® Maker Submitted Pre-Submission Supplement to US FDA
June 1st, 2016
GlucoTrack® Maker Submitted Pre-Submission Supplement to US FDA SHDOD, Israel, June 1, 2016 /PRNewswire/ – Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a noninvasive device for measuring glucose levels of people with Type 2 diabetes, announced that it has set a conference call with the United States Food and Drug Administration (FDA), expected to […]
Read More DownloadGlucoTrack® maker to Present at Marcum and LD Micro Investor Conferences on June 2nd in New York City and June 7th in Los Angeles
June 1st, 2016
GlucoTrack® maker to Present at Marcum and LD Micro Investor Conferences on June 2nd in New York City and June 7th in Los Angeles ASHDOD, Israel, May 31, 2016 /PRNewswire/ – Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a noninvasive device for measuring glucose levels of people with Type 2 diabetes and pre-diabetics, announced […]
Read More DownloadGlucoTrack® Maker Names Two New Board Members
March 24th, 2016
Ashdod, Israel, March 23, 2016 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels of people with Type 2 diabetes and pre-diabetics, announced today that it appointed Angela Strand and Leslie Seff to its Board of Directors, effective March 23, 2016. Ms. Strand will also chair the […]
Read More DownloadGlucoTrack® Maker Receives New EU Certification
February 20th, 2016
Annex II Certification Enables Faster Sales On Modified Products ASHDOD, Israel, Feb. 19, 2016 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels of people with Type 2 diabetes and pre-diabetics, today announced that it has received an extension of its ISO 13485:2003 certificate and Annex II […]
Read More
